Plain-English translation of NCT06094569 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
When a blood vessel in the back of your brain becomes blocked by a clot, doctors need to decide quickly whether to perform a procedure called mechanical thrombectomy (a minimally invasive surgery to remove the clot). This study uses a special measurement system applied to MRI brain scans—called the pons-midbrain-medulla index—to predict which patients are most likely to recover well after treatment. By analyzing how much brain tissue is affected by the stroke, researchers hope to help doctors make better decisions about who should receive this clot-removal procedure.
Previous research suggests that using MRI scans before clot-removal surgery leads to better outcomes than using CT scans alone. However, doctors still need better tools to predict which patients will truly benefit from this procedure. This study aims to validate a new scoring system that measures the extent of brain damage on MRI, so doctors can confidently identify patients most likely to recover well.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will receive either the clot-removal procedure (mechanical thrombectomy) with the best available medical care, or the best medical care alone. Before treatment, your brain will be scanned with MRI, and doctors will measure the extent of your stroke using the new scoring system. Your medical team will then use this information to guide treatment decisions. Researchers will follow your recovery and compare how well the scoring system predicted outcomes at 90 days after treatment.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
China